Health Catalyst, Inc. (HCAT) insider trading

By person

33 insiders · 403 transactions

4.7×

Daniel Burton holds only 4.7 times base salary in stock. $2.49M of shares against $525.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Burton last reported holding, valued at $1.79, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Daniel D. Burton

Chief Executive Officer

$5.75M (5)

$49.81M (41) scheduled

−$44.06M

1,393,099

1.85%

$2.49M

—

James Patrick Nelli Jr.

President

—

$10.83M (24) scheduled

−$10.83M

265,025

0.3522%

$473.63K

+3,977%

Paul Horstmeier

Chief Operating Officer

—

$10.74M (70) scheduled

−$10.74M

204,880

0.2722%

$366.14K

+1,280%

Anita Pramoda

Director

—

$7.41M (15) scheduled

−$7.41M

70,851

0.0941%

$126.62K

+458.1%

Dale Sanders

Chief Technology Officer

—

$5.57M (13) scheduled

−$5.57M

164,484

0.2186%

$293.95K

+173.8%

Daniel H. Orenstein

General Counsel

—

$4.78M (40) scheduled

−$4.78M

133,097

0.1769%

$237.86K

—

Linda Llewelyn

Chief People Officer

—

$3.73M (83) scheduled

−$3.73M

321,132

0.4267%

$573.89K

+200,608%

Timothy G. Ferris

Director

—

$1.18M (10) scheduled

−$1.18M

5,443

0.0072%

$9.73K

—

D Fraser Bullock

Director

—

$1.11M (5)

−$1.11M

44,999

0.0598%

$80.42K

—

Jason Alger

Chief Financial Officer

—

$776.42K (16)

−$776.42K

704,867

0.9366%

$1.26M

+6,134%

Bryan Richard Hinton

Chief Technology Officer

—

$673.85K (17)

−$673.85K

26,403

0.0351%

$47.18K

+5.6%

Daniel LeSueur

Chief Operating Officer

—

$649.85K (12) scheduled

−$649.85K

198,367

0.2636%

$354.50K

+84.5%

Benjamin Landry

General Counsel

—

$515.48K (12) scheduled

−$515.48K

351,372

0.4669%

$627.94K

+2,215%

Kevin Lee Freeman

Chief Commercial Officer

—

$170.26K (3)

−$170.26K

358,686

0.4766%

$641.01K

+486.5%

Julie Larson-Green

Director

—

$128.35K (1)

−$128.35K

185,101

0.2460%

$330.79K

—

Bryan Truman Hunt

Chief Financial Officer

—

$120.14K (5)

−$120.14K

219,849

0.2921%

$392.89K

+1,465%

Duncan Gallagher

Director

$174.95K (2)

$62.60K (2) scheduled

+$112.35K

132,023

0.1754%

$235.94K

—

Simeon Kohl

Chief Executive Officer

$105.44K (1)

—

+$105.44K

2,856,385

3.80%

$5.10M

+5,613%

Promod Haque

10% owner

—

4,707,737

6.26%

$8.41M

+292.7%

Sc Us (Ttgp), Ltd. entity

10% owner

—

3,707,029

4.93%

$6.62M

—

Norwest Venture Partners XI, LP entity

10% owner

—

3,504,304

4.66%

$6.26M

—

Benjamin Albert

CEO

—

1,388,406

1.84%

$2.48M

+1,152%

Todd C Cozzens

Director

—

1,371,348

1.82%

$2.45M

+275.3%

Steven H Nelson

Director

—

235,499

0.3129%

$420.86K

—

David Coy Ross

Chief Tech & Product Officer

—

204,219

0.2714%

$364.96K

−1.6%

John A Kane

Director

—

170,719

0.2268%

$305.09K

+297.1%

Justin Spencer

Director

—

149,263

0.1983%

$266.75K

—

Green Jill Hoggard

Director

—

144,628

0.1922%

$258.46K

—

Tami Reller

Director

—

128,851

0.1712%

$230.27K

—

S. Dawn Smith

Director

—

101,692

0.1351%

$181.73K

—

Anne Marie Bickmore

COO and Chief Product Officer

—

63,720

0.0847%

$113.87K

+75.7%

Michael Edward Dixon

Director

—

54,199

0.0720%

$96.86K

—

Mark B Templeton

Director

—

39,360

0.0523%

$70.34K

—

Health Catalyst, Inc.

What the insiders did Net selling

By person